Skip to main content
. 2022 Oct 27;13:1013049. doi: 10.3389/fimmu.2022.1013049

Figure 7.

Figure 7

Different paradigms of DNA replication stress and drug sensitivity in the E2F-Clust and ImmClust. (A) Activities of 21 pathways related to DNA replication stress in the E2F-Clust and ImmClust. There was evident downregulation of DNA replication stress in the CS3 subtype. (B) The E2F-Clust stratified patients into two groups with distinct differences in clinical TNM stages and progression-free survival. (C) IC50 (half maximal inhibitory concentration) of typical inhibitors targeting ATR and week 1 protein. Patients of CS2 showed a tendency to be drug resistant. ***P < 0.001.